Navigation Links
Chindex International, Inc. Announces Results for the Quarter and Six Months Ended September 30, 2007
Date:11/7/2007

(280,000)

Income from continuing operations

before income taxes $3,699,000

Healthcare Medical

Services Products Total

As of March 31, 2007:

Assets $34,129,000 $28,778,000 $62,907,000

For the six months ended September

30, 2006:

Sales and service revenue $22,407,000 $28,487,000 $50,894,000

Gross Profit n/a* 7,239,000 n/a

Gross Profit % n/a* 25% n/a

Income from continuing operations

before foreign exchange $2,282,000 $179,000 $2,461,000

Foreign exchange gain 71,000

Income from continuing operations $2,532,000

Other (expense), net (257,000)

Income from continuing operations

before income taxes $2,275,000

* Gross profit margins are not routinely calculated in the healthcare industry.

For more information, please contact:

Lawrence Pemble

Judy Zakreski

Chindex International, Inc.

Tel: +1-301-215-7777


'/>"/>
SOURCE Chindex International, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
2. Arrow International, Inc. Invites You to Join Its 2007 Annual Meeting of Shareholders on the Web
3. Natural Alternatives International, Inc. Announces Late Filing of its Annual Report on Form 10-K, Revenue for Fiscal 2007 and Guidance on First Quarter of Fiscal 2008
4. Cryo-Cell International, Inc. Reports Third Quarter 2007 Results
5. TenderCare International, Inc. Announces Signing of Merger Agreement with the Hain Celestial Group for All Outstanding Shares of TenderCare Stock
6. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
7. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
8. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
9. HEI, Inc. Announces Sale of RFID Division Assets
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
11. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)..., Innovative medical appa...9 conference , San Clemen...eg;, maker of breakthrough medical apparel, today ... are on display at Medica 2009, a leading internat...Dusseldorf, Germany. Medelita inaugurates its men,...
(Date:11/21/2009)..., Eric J. Hall, president...undation of America (AFA) issued the following sta...ment detection as part of the new annual wellness ...otection and Affordable Care Act" that was in...w York, NY (PRWEB) November 21, 2009 -- Eric J. Ha...
(Date:11/21/2009)..., Linwood Group ask wheth...d can it be measured? , L...up reveal that with up to one in three of the adul...a risk of developing alcohol-related liver disease...gly turning to rehabilitation programmes and resid...
(Date:11/20/2009)..., , PRINCETON, NJ, Nov. 20 /PRNewswire-Fi... today that a Special Meeting of Shareholders will... of the Meeting is to consider approval of two spe...to approve and authorize the sale of all or substa...y on the terms provided for in the asset purchase ...
(Date:11/20/2009)..., , WASHINGTON, Nov. 20 /PRNewswire-U...olic Bishops urged the Senate to make essential ch...lace federal law on abortion funding and conscienc... care for immigrants and include strong provisions...led the Senate health care bill an "enormous disap...
Breaking Medicine News(10 mins):Health News:Medelita Introduces Men's Lab Coat Collection 2Health News:Medelita Introduces Men's Lab Coat Collection 3Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 2Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 4Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:U.S. Bishops Voice Disappointment in Abortion-Funding Provisions in Senate Health Bill, Urge Better Care for Immigrants and Affordability 2
... With so much riding on new,product development an...y,seeking to improve the expensive and time-consum...ompetition, leading firms are focusing more,market...nies limit marketing spending in early,stages to 1...
...outcomes of ongoing clinical trials, expert says ,...espite some reports that statins might slow or pre...dence for the theory. , While some animal studies... between statin use and the risk of Alzheimer,s di...
...itute launched a new one-of-a-kind service for the...ication Microarray Service (MIM) enables the rapid...amples. The first service offering, Human Oral Mic...e bacterial associations in health vs. disease, mo...
...expected this spring, officials add , , T... and Drug Administration on Thursday issued a publ...ough and cold medicines should not be given to inf...cent months, FDA officials said they were concerne...
...he Terminator to the Bionic Woman use bionic eyes ...p into their field of view, or create virtual cros... proposed for more practical purposes visual aids... be familiar. Engineers at the University of Washi...
...ead One of the Nation,s Largest ...7 Bruce D. Lindsay, M.D., currently,Professor of ... at,Washington University in St. Louis, has been a...he field of,electrophysiology join our team and co...
Other Medicine News:Health News:Using Product Marketing to Launch Drugs That Outperform the Competition 2Health News:Latest Study Says Statins Don't Slow Alzheimer's 2Health News:Forsyth launches 1-of-a-kind core service to enable rapid identification of bacterial samples 2Health News:Cold Meds Not Safe for Kids Under 2, FDA Warns 2Health News:Cold Meds Not Safe for Kids Under 2, FDA Warns 3Health News:Cold Meds Not Safe for Kids Under 2, FDA Warns 4Health News:Contact lenses with circuits, lights a possible platform for superhuman vision 2Health News:Contact lenses with circuits, lights a possible platform for superhuman vision 3Health News:Cleveland Clinic Recruits World Renowned Heart Rhythm Specialist to Direct Electrophysiology 2
(Date:11/20/2009)...PRNewswire-FirstCall/ -- Escalon Medical Corp. (Na...iscal first quarter ended September 30, 2009. ,...revenue decreased approximately $234,000, or 2.7%,... September 30, 2009 as compared to the same period...ased net revenue of $8,434,000 compared with $8,66...
(Date:11/20/2009)... Unilens Vision Inc. (OTC..., which develops, licenses, manufactures, distribu...ported its operating results for the first quarter...s excluding royalty income, were $1,683,673 in the...eported in the previous year first quarter (FY2009...
(Date:11/20/2009)...ov. 20 The National Association of...ced a new initiative in the war on methamphetamine...a multi-state electronic tracking program that enf...C) medicines containing pseudoephedrine in real-ti... is based on a system that was developed and teste...
Breaking Medicine Technology:Escalon(R) Reports First Quarter Fiscal 2010 Results 2Escalon(R) Reports First Quarter Fiscal 2010 Results 3Escalon(R) Reports First Quarter Fiscal 2010 Results 4Escalon(R) Reports First Quarter Fiscal 2010 Results 5Escalon(R) Reports First Quarter Fiscal 2010 Results 6Escalon(R) Reports First Quarter Fiscal 2010 Results 7Unilens Vision Reports Record First Quarter Earnings and Royalty Income 2Unilens Vision Reports Record First Quarter Earnings and Royalty Income 3Unilens Vision Reports Record First Quarter Earnings and Royalty Income 4National System Aims To Minimize Diversion of Cold and Allergy Medicine in Methamphetamine Production 2National System Aims To Minimize Diversion of Cold and Allergy Medicine in Methamphetamine Production 3Journal of Midwifery 26amp 3B Womens Health honors outstanding authors 54619 1Journal of Midwifery 26amp 3B Womens Health honors outstanding authors 54619 2Imagenetix Inc Announces Interview With Bloomberg Radio 13589 1Imagenetix Inc Announces Interview With Bloomberg Radio 13589 2Real World Study Showed Cost Savings for VTE Prophylaxis with Enoxaparin Compared with Unfractionated Heparin 28UFH 29 4856 1Real World Study Showed Cost Savings for VTE Prophylaxis with Enoxaparin Compared with Unfractionated Heparin 28UFH 29 4856 2Real World Study Showed Cost Savings for VTE Prophylaxis with Enoxaparin Compared with Unfractionated Heparin 28UFH 29 4856 3Real World Study Showed Cost Savings for VTE Prophylaxis with Enoxaparin Compared with Unfractionated Heparin 28UFH 29 4856 4
...gentina, May 21 Today at the,World Congress of Ca...,Perspectives in Atrial Fibrillation Management" c...gy, St George,s University of London,highlighted t...al trial,results, as the way forward in the future...n form of cardiac arrhythmia., To view the Multim...
...gnificant Reduction of IBS Pain and Normalizing Mo... SAN DIEGO, May 20 Tioga Pharmaceuticals, Inc. t...udy of its oral kappa opioid,receptor agonist, asi...cant,results in the treatment of Irritable Bowel S...provement in diarrhea-predominant (D-IBS) and,alte...
Other Medicine Technology:ATHENA Clinical Results for Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress 2ATHENA Clinical Results for Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress 3ATHENA Clinical Results for Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress 4ATHENA Clinical Results for Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress 5ATHENA Clinical Results for Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress 6Tioga Pharmaceuticals' Asimadoline Demonstrates Positive Results in a Phase 2b Clinical Trial for the Treatment of Irritable Bowel Syndrome 2Tioga Pharmaceuticals' Asimadoline Demonstrates Positive Results in a Phase 2b Clinical Trial for the Treatment of Irritable Bowel Syndrome 3Tioga Pharmaceuticals' Asimadoline Demonstrates Positive Results in a Phase 2b Clinical Trial for the Treatment of Irritable Bowel Syndrome 4
Chin Support Bandage
Facial Garments
Facial Mask
Deluxe Abdominal Binders
Medicine Products: